Gambogic acid inhibits the growth of osteosarcoma cells in vitro by inducing apoptosis and cell cycle arrest

Oncology Reports

Volumn 25, Issue 5, 2011, Pages 1289-1295

  Zhao, Wei ^a   Zhou, Shi Feng ^a   Zhang, Zhi Peng ^a   Xu, Gong Ping ^a   Li, Xiao Bo ^b   Yan, Jing Long ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Apoptosis; Cycle arrest; Gambogic acid; Osteosarcoma

Indexed keywords

CYCLIN DEPENDENT KINASE 1; GAMBOGIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN TYROSINE PHOSPHATASE; SERINE; THREONINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS INHIBITION; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; UPREGULATION;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OSTEOSARCOMA; XANTHONES;

EID: 79953030677     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1189     Document Type: Article

References (39)

1. Longhi A, Errani C, De Paolis M, Mercuri M and Bacci G Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 32: 423-436, 2006. (Pubitemid 44309249)
2. Rosen G, Caparros B, Huvos AG, et al: Preoperative chemotherapy for osteogenic sarcoma: selection of posteoperative adjurant chemotherapy based on the response of primary tumor to preoperative chemotherapy. Cancer 49: 1221-1230, 1982. (Pubitemid 12187826)
3. Goorin AM, Harris MB, Bernstein M, et al: Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. J Qin Oncol 20: 426-433, 2002. (Pubitemid 34072525)
4. Rybak LP, Husain K, Morris C, Whitworth C and Somani S: Effect of protective agents against cisplatin ototoxicity. Am J Otol 21: 513-520, 2000. (Pubitemid 30432460)
5. Krischer JP, Epstein S, Cuthbertson DD, Goorin AM, Epstein ML and Lipshultz SE: Clinical cardiotoxicity following a thracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol 15: 1544-1552, 1997. (Pubitemid 27167391)
6. Longhi A, Macchiagodena M, Vitali G and Bacci G. Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma. J Pediatr Hematol Oncol 25: 292-296, 2003. (Pubitemid 36506215)
7. Lee PD, Noble-Topham SE, Bell RS and Andrulis IL: Quantitative analysis of multidrug resisrance gene expression in human osteosarcoma. Br J Cancer 74: 1046-1050, 1996. (Pubitemid 26333904)
8. Pösl M, Gahl K, Amling M, et al: P-glycoprotein expression in osteosarcoma. Pathologe 17: 50-55, 1996.
9. Yang Y, Yang L, You QD, et al: Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes. Cancer Lett 256: 259-266, 2007. (Pubitemid 47418351)
10. Zhao L, Guo QL, You QD, Wu ZQ and Gu HY: GA induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells. Biol Pharm Bull 27: 998-1003, 2004. (Pubitemid 41701748)
11. Liu W, Guo QL, You QD, Zhao L, Gu HY and Yuan ST: Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823. World J Gastroenterol 11: 3655-3659, 2005. (Pubitemid 41149258)
12. Chen J, Gu HY, Lu N, et al: Microtubule de polymerization and phosphorylation of c-Jun N-terminal kinase-1 and p38 were involved in gambogic acid induced cell cycle arrest and apoptosis in human breast carcinoma MCF-7 cells. Life Sci 83: 103-109, 2008.
13. Lu N, Yang Y, You QD, et al: GA inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1. Cancer Lett 258: 80-89, 2007. (Pubitemid 47600491)
14. Wang T, Wei J, Qian X, Ding Y, Yu L and Liu B: GA, a potent inhibitor of survivin, reverses docetaxel resistance in gastric cancer cells. Cancer Lett 262: 214-222, 2008.
15. Qiang L, Yang Y, You QD, et al: Inhibition of glioblastoma growth and angiogenesis by gambogic acid: An in vitro and in vivo study. Biochem Pharmacol 75: 1083-1092, 2008.
16. Gu H, You Q, Liu W, et al: GA induced tumor cell apoptosis by T lymphocyte activation in H22 transplanted mice. Int Immunopharmacol 8: 1493-1502, 2008.
17. Wu ZQ, Guo QL, You QD, Zhao L and Gu HY: GA inhibits proliferation of human lung carcinoma SPC-A1 cells in vivo and in vitro and represses telomerase activity and telomerase reverse transcriptase mRNA expression in the cells. Biol Pharm Bull 27: 1769-1774, 2004. (Pubitemid 41701601)
18. Guo Q, Qi Q, You Q, Gu H, Zhao L and Wu Z: Toxicological studies of gambogic acid and its potential targets in experimental animals. Basic Qin Pharmacol Toxicol 99: 178-184, 2006. (Pubitemid 44213948)
19. Qi Q, You Q, Gu H, Zhao L, Liu W, Lu N and Guo Q: Studies on the toxicity of gambogic acid in rats. J Ethnopharmacol 117: 433-438, 2008.
20. Danial NN and Korsmeyer SJ: Cell death: critical control points. Cell 116: 205-219, 2004. (Pubitemid 38167313)
21. Adams JM and Cory S: The Bcl-2 protein family: arbiters of cell survival. Science 281: 1322-1326, 1998. (Pubitemid 28406819)
22. Gross A, McDonnell JM and Korsmeyer SJ: BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13: 1899-1911, 1999.
23. Strasser A, Harris AW, Huang DC, Krammer PH and Cory S: Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 14: 6136-6147, 1995. (Pubitemid 26007301)
24. Oltvai ZN, Milliman CL and Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993. (Pubitemid 23259742)
25. Lindsten T, Ross AJ, King A, et al: The combined functions of proapoptotic Bcl-2 family members bak and Bax are essential for normal development of multiple tissues. Mol Cell 6: 1389-1399, 2000.
26. Gu H, Rao S, Zhao J, et al: GA reduced Bcl-2 expression via p53 in human breast MCF-7 cancer cells. J Cancer Res Clin Oncol 135: 1777-1782, 2009.
27. Xu X, Liu Y, Wang L, et al: GA induces apoptosis by regulating the expression of Bax and Bcl-2 and enhancing caspase-3 activity in human malignant melanoma A375 cells. Int J Dermatol 48: 186-192, 2009.
28. Li R, Chen Y, Zeng LL, Shu WX, Zhao F, Wen L and Liu Y: GA induces G0/G1 arrest and apoptosis involving inhibition of SRC-3 and inactivation of Akt pathway in K562 leukemia cells. Toxicology 262: 98-105, 2009.
29. Yu J, Guo QL, You QD, et al: GA-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of cdc2/ p34 in human gastric carcinoma BGC-823 cells. Carcinogenesis 28: 632-638, 2007. (Pubitemid 46523358)
30. Plyte SE, Hughes K, Nikolakaki E, Purverer BJ and Woodgett JR: Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim Biophys Acta 1114: 147-162, 1992. (Pubitemid 23008367)
31. Diehl JA, Cheng M, Roussel MF and Sherr CJ: Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499-1511, 1998.
32. Serrano M , Hannon GJ and Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707, 1993. (Pubitemid 24036021)
33. Shaw M, Cohen P and Alessi DR: Further evidence that the inhibition of glycogen synthase kinase-3β by IGF-1 is mediated by PDK1/PKB-induced phosphorylation of Ser-9 and not by dephosphorylation of Tyr-216. FEBS Lett 416: 307-311, 1997. (Pubitemid 27475387)
34. Galaktionov K and Beach D: Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell 67: 1181-1194, 1991. (Pubitemid 121001530)
35. Sebastian B, Kakizuka A and Hunter T: Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of Threonine-14 and tyrosine-15. Proc Natl Acad Sci USA 90: 3521-3524, 1993. (Pubitemid 23111398)
36. Hoffmann I, Draetta G and Karsenti E : Activation of the phosphatase activity of human cdc25A by a CDK2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J 13: 4302-4310, 1994. (Pubitemid 24295202)
37. Hoffmann I, Clarke PR, Marcote MJ, Karsenti E and Draetta G. Phosphorylation and activation of human cdc25-C by cdc2-cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO J 12: 53-63, 1993. (Pubitemid 23042382)
38. Lammer C, Wagerer S, Saffrich R, Mertens D, Ansorge Wand Hoffmann I: The cdc25B phosphatase is essential for the G2/M phase transition in human cells. J Cell Sci 111: 2445-2453, 1998. (Pubitemid 28434930)
39. Karlsson C, Katich S, Hagting A, Hoffmann I and Pines J: Cdc25B and Cdc25C differ markedly in their properties as initiators of mitosis. J Cell Biol 146: 573-584, 1999.